Cost-effectiveness of inhaled fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease (COPD)

被引：0
|
作者：
Hurrell, C [1 ]
Price, MJ [1 ]
Hollingworth, KE [1 ]
Thwaites, RMA [1 ]
机构：
[1] Glaxo Wellcome, Greenford, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A797 / A797
页数：1
相关论文
共 50 条
  • [1] Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease
    Briggs, A
    Wang, H
    Gagnon, YM
    Spencer, S
    Bale, G
    Spencer, M
    Burge, S
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 246 - 247
  • [2] Cost-effectiveness of salmeterol/fluticasone propionate in the treatment of COPD
    Earnshaw, Stephanie R.
    Wilson, Michele R.
    Blanchette, Christopher M.
    Mapel, Doug W.
    [J]. CHEST, 2007, 132 (04) : 528S - 528S
  • [3] Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data
    Briggs, Andrew H.
    Lozano-Ortega, Greta
    Spencer, Sally
    Bale, Geraldine
    Spencer, Michael D.
    Burge, P. Sherwood
    [J]. VALUE IN HEALTH, 2006, 9 (04) : 227 - 235
  • [4] Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease
    Lee, TA
    Weiss, KB
    Sullivan, SD
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08): : 618 - 618
  • [5] COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN SPAIN
    Brosa, M.
    Diaz, S.
    Miravitlles, M.
    Gonzalez-Rojas, N.
    Nieves, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A302 - A302
  • [6] Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial
    Ayres, JG
    Price, MJ
    Efthimiou, J
    [J]. RESPIRATORY MEDICINE, 2003, 97 (03) : 212 - 220
  • [7] The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator
    Neyt, Mattias
    Van den Bruel, Ann
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (04): : 379 - 380
  • [8] COST-EFFECTIVENESS OF ROFLUMILAST (DAXAS®) IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Lindner, L.
    Camins de Valdenebro, L.
    Aparicio Martinez, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [9] Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease
    Singh, SD
    Whale, C
    Houghton, N
    Daley-Yates, P
    Kirby, SM
    Woodcock, AA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 375 - 381
  • [10] The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator
    Mattias Neyt
    Ann Van Den Bruel
    [J]. The European Journal of Health Economics, 2012, 13 : 379 - 380
12345